Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. CVS
CVS logo

CVS Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
93.580
Open
92.670
VWAP
91.71
Vol
9.73M
Mkt Cap
116.08B
Low
90.570
Amount
892.34M
EV/EBITDA(TTM)
9.51
Total Shares
1.28B
EV
167.57B
EV/OCF(TTM)
16.22
P/S(TTM)
0.28
CVS Health Corporation is a health solutions company. The Company's segments include Health Care Benefits, Health Services, Pharmacy & Consumer Wellness and Corporate/Other. The Health Care Benefits segment offers a broad range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental and behavioral health plans, PDPs and Medicaid health care management services. The Health Services segment provides a full range of pharmacy benefit management (PBM) solutions through its CVS Caremark operations and delivers health care services in its medical clinics, virtually, and in the home. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its CVS Pharmacy retail locations and, through its infusion operations, provides ancillary pharmacy services including pharmacy patient care programs, and vaccination administration, and sells a wide assortment of health and wellness products and general merchandise.
Show More

Events Timeline

(ET)
2026-05-28
08:20:00
ARCTRUST Acquires Seven Property Single-Tenant Portfolio
select
2026-05-28
07:40:00
Salesforce and CVS Health Expand Collaboration
select
2026-05-28
07:00:00
Eli Lilly Announces Coverage of Obesity Drugs by Three Major PBMs
select
2026-05-28
07:00:00
CVS Health Updates Commercial Formularies, Reintroduces Zepbound
select
2026-05-13 (ET)
2026-05-13
16:10:00
CVS Health Subsidiary Omnicare Sold to GenieRx
select

News

PRnewswire
3.5
05-29PRnewswire
CVS Health Wins 2026 Newsweek AI Impact Award
  • Award Recognition: CVS Health has been awarded the 2026 Newsweek AI Impact Award for its AI-Driven Prescription Interpretation technology, highlighting its commitment to enhancing patient care through innovative AI integration in pharmacy workflows.
  • Patient Safety Enhancement: By deploying trained open-source large language models, CVS Health effectively addressed the manual transcription burden of complex prescription instructions, thereby increasing the time clinicians can dedicate to direct patient support.
  • Significant Outcomes in Pharmacy: The automation in retail pharmacy accelerates prescription fulfillment and reduces delays, while in specialty pharmacy, the tool enables quicker patient onboarding and prescription filling, enhancing the overall patient experience.
  • Ongoing Performance Evaluation: CVS Health prioritizes patient safety and responsible AI deployment, continuously evaluating model performance against pharmacy accuracy benchmarks and ensuring pharmacists maintain final clinical authority through human-in-the-loop safeguards.
Newsfilter
3.5
05-29Newsfilter
CVS Health Wins 2026 Newsweek AI Impact Award
  • Award Recognition: CVS Health has been awarded the 2026 Newsweek AI Impact Award for its AI-driven prescription interpretation technology, highlighting the company's innovative capabilities and commitment to patient care in the healthcare sector.
  • Efficiency Improvement: By embedding intelligent automation into pharmacy workflows, CVS Health enables pharmacists and technicians to focus more on clinical support, thereby enhancing patient care quality and reducing administrative burdens.
  • Rapid Prescription Processing: The technology significantly accelerates prescription fulfillment in both retail and specialty pharmacies, particularly aiding patients in specialty settings to begin therapy faster, thus improving their treatment experience.
  • Ongoing Performance Evaluation: CVS Health has maintained patient safety and responsible AI deployment as foundational design principles, ensuring model performance meets pharmacy accuracy benchmarks while incorporating human-in-the-loop safeguards to uphold pharmacists' clinical authority.
Yahoo Finance
8.5
05-29Yahoo Finance
Eli Lilly Shares Surge After CVS Restores Zepbound and Adds Foundayo
  • Stock Price Surge: Eli Lilly's shares rose 3.4% to $1,124 in afternoon trading, reflecting positive market sentiment following CVS's restoration of Zepbound as a co-preferred option, indicating strong investor confidence in the company's new drug offerings.
  • Increased Drug Accessibility: With CVS Caremark covering approximately 25 to 30 million Americans, Eli Lilly's full obesity medication portfolio is now accessible through the three largest pharmacy benefit managers in the U.S., which is expected to significantly enhance market penetration for its products.
  • Importance of Foundayo: Foundayo, as Eli Lilly's oral GLP-1 medication, addresses the barrier of needle aversion, and its inclusion in CVS's formulary is likely to accelerate market acceptance and reduce the typical access hurdles faced by new drugs.
  • Investment and Demand Growth: Eli Lilly has invested $21 billion in U.S. manufacturing capabilities to meet surging demand for its weight-loss medications, particularly after clinical trials for Foundayo showed significant weight loss in adults aged 65 and older, further boosting market confidence in the company's growth prospects.
Fool
9.5
05-28Fool
CVS Health Stock Rises; Analyzing Dividend Sustainability
  • Stock Recovery: CVS Health's stock has surged over 107% since the beginning of 2025, indicating a growing market confidence in its future prospects after several years of struggles, which may attract more investor interest.
  • Dividend Appeal: With a current dividend yield of nearly 2.9%, CVS's yield is more than 2.5 times that of the S&P 500, highlighting its attractiveness; however, the sustainability of this dividend remains a key concern for long-term investors.
  • Cash Flow Health: In the most recent quarter, CVS generated $4.2 billion in operating cash flow, down from $4.6 billion last year, yet still sufficient to cover its $847 million in dividend payouts, demonstrating the company's financial robustness.
  • Future Projections: CVS expects its cash flow to reach at least $9.5 billion this year, comfortably covering the projected $3.39 billion in dividends, and while the company has paused annual dividend increases, its healthy cash flow supports ongoing dividend payments.
NASDAQ.COM
8.0
05-28NASDAQ.COM
Analysis of CVS Health's Dividend Sustainability
  • Cash Flow Coverage: In the most recent quarter, CVS Health generated $4.2 billion in cash flow, which, despite a decrease from last year, was sufficient to cover its $847 million dividend payout, demonstrating the company's robust cash flow management.
  • Dividend Yield Advantage: Currently, CVS's dividend yield is nearly 2.9%, more than 2.5 times that of the S&P 500, and while stock growth has stagnated, its dividend remains a key attraction for investors, highlighting its importance in the current market.
  • Future Cash Flow Expectations: CVS expects its cash flow to reach at least $9.5 billion this year, comfortably covering the projected $3.39 billion in dividends, indicating financial stability and the sustainability of its dividend payments.
  • Dividend Growth Pause: Although CVS has paused annual dividend increases in recent years to pay down Aetna acquisition debt, its healthy cash flow alleviates concerns about potential dividend cuts, reflecting a cautious approach to financial management.
stocktwits
8.5
05-28stocktwits
CVS Restores Coverage for Eli Lilly's Weight Loss Drug
  • Coverage Restoration: CVS Caremark will restore coverage for Eli Lilly's weight loss injection Zepbound as a preferred option starting October 1, significantly enhancing patient access and treatment options.
  • New Drug Launch: Eli Lilly's newly approved obesity pill Foundayo will be available on plans from June 1, 2026, further enriching the company's portfolio in obesity treatment and strengthening its market competitiveness.
  • Stock Milestone: Eli Lilly's shares hit an all-time high of $1,147.95 on Thursday, pushing its market capitalization to approximately $1.02 trillion, reflecting strong market demand for its obesity drugs and future growth potential.
  • Competitive Landscape Shift: CVS's decision came after Eli Lilly agreed to lower drug prices, which will help Lilly compete more effectively with rival Novo Nordisk in the rapidly growing weight-loss market, enhancing its market share.
Wall Street analysts forecast CVS stock price to rise
17 Analyst Rating
Wall Street analysts forecast CVS stock price to rise
16 Buy
1 Hold
0 Sell
Strong Buy
Current: 0.000
sliders
Low
91.00
Averages
96.71
High
105.00
Current: 0.000
sliders
Low
91.00
Averages
96.71
High
105.00
Barclays
Andrew Mok
Overweight
maintain
$101 -> $106
AI Analysis
2026-05-26
Reason
Barclays
Andrew Mok
Price Target
$101 -> $106
AI Analysis
2026-05-26
maintain
Overweight
Reason
Barclays analyst Andrew Mok raised the firm's price target on CVS Health to $106 from $101 and keeps an Overweight rating on the shares. The firm believes the managed care stock moves post the Q1 reports are "durable." It continues to prefer managed care over facilities, saying inflation and commercial mix represent increasing drivers of provider earnings risk. Barclays adjusted ratings and targets in the group.
Mizuho
Outperform
maintain
$102 -> $110
2026-05-20
Reason
Mizuho
Price Target
$102 -> $110
2026-05-20
maintain
Outperform
Reason
Mizuho raised the firm's price target on CVS Health to $110 from $102 and keeps an Outperform rating on the shares. The firm views the Q1 reports in the manage care group as solid. It cites a reduced likelihood of negative medical loss ratio shifts through the end of 2026 for the target bump.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for CVS
Unlock Now

Valuation Metrics

The current forward P/E ratio for CVS Health Corp (CVS.N) is 12.50, compared to its 5-year average forward P/E of 10.35. For a more detailed relative valuation and DCF analysis to assess CVS Health Corp's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PE
10.35
Current PE
12.50
Overvalued PE
11.77
Undervalued PE
8.93

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average EV/EBITDA
10.26
Current EV/EBITDA
9.99
Overvalued EV/EBITDA
14.73
Undervalued EV/EBITDA
5.79

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PS
0.29
Current PS
0.28
Overvalued PS
0.38
Undervalued PS
0.20

Financials

AI Analysis
Annual
Quarterly

Related Community Screener

what stock is pushing the market now
Intellectia · 111 candidates
Market Cap Category: largeRsi Category: moderateRelative Vol: >= 1.50Moving Average Relationship: PriceAboveMA20, PriceAboveMA200Week Price Change Pct: >= $0.00Month Price Change Pct: >= $0.00Is Index Component: GSPC, NDX, DJI
Ticker
Name
Market Cap$
top bottom
MRVL logo
MRVL
Marvell Technology Inc
173.97B
TMO logo
TMO
Thermo Fisher Scientific Inc
169.54B
GILD logo
GILD
Gilead Sciences, Inc
165.99B
GLW logo
GLW
Corning Inc
164.29B
HON logo
HON
Honeywell International Inc
146.72B
CRM logo
CRM
Salesforce Inc
145.21B
option with low spread for today
Intellectia · 192 candidates
Price: $20.00 - $500.00Market Cap Category: large, midRelative Vol: >= 1Is Optionable: TrueOption Iv Rank: 20 - 60Is Index Component: GSPC, NDX, DJI, RUT
Ticker
Name
Market Cap$
top bottom
NEE logo
NEE
Nextera Energy Inc
194.60B
DIS logo
DIS
Walt Disney Co
188.69B
BA logo
BA
Boeing Co
182.12B
ANET logo
ANET
Arista Networks Inc
178.49B
TMO logo
TMO
Thermo Fisher Scientific Inc
176.32B
T logo
T
AT&T Inc
175.52B
I need AI to pick a stock and manage it
Intellectia · 2 candidates
Sector: Healthcare, Healthcare Services & Equipment, Pharmaceuticals & Medical ResearchIndustry: Food & Drug Retailing, Healthcare Equipment & Supplies, Healthcare Providers & Services, PharmaceuticalsVolume: >= -100Themes: Medical Instruments & Supplies, Pharmaceutical RetailersRsi Category: moderateMoving Average Relationship: PriceAboveMA5, PriceAboveMA20Monthly Average Dollar Volume: >= -100Macd: positive, bullish
Ticker
Name
Market Cap$
top bottom
CVS logo
CVS
CVS Health Corp
103.78B
EW logo
EW
Edwards Lifesciences Corp
47.44B
which stocks to buy short term
Intellectia · 40 candidates
Moving Average Relationship: PriceAboveMA20Week Price Change Pct: $4.00 - $12.00Is Index Component: GSPC
Ticker
Name
Market Cap$
top bottom
ELV logo
ELV
Elevance Health Inc
74.87B
QCOM logo
QCOM
Qualcomm Inc
158.82B
VTR logo
VTR
Ventas Inc
39.76B
KDP logo
KDP
Keurig Dr Pepper Inc
39.76B
PKG logo
PKG
Packaging Corp of America
18.95B
BKR logo
BKR
Baker Hughes Co
68.37B
today's stock picks
Intellectia · 74 candidates
Volume: >= 1,000,000Price Change Pct: $1.00 - $10.00List Exchange: XNYS, XNASMoving Average Relationship: PriceAboveMA20Is Index Component: GSPC, NDX
Ticker
Name
Market Cap$
top bottom
KO logo
KO
Coca-Cola Co
329.83B
NUE logo
NUE
Nucor Corp
48.80B
MOH logo
MOH
Molina Healthcare Inc
9.17B
BEN logo
BEN
Franklin Resources Inc
14.12B
UDR logo
UDR
UDR Inc
11.42B
AVB logo
AVB
AvalonBay Communities Inc
23.98B
yes stocks
Intellectia · 27 candidates
Market Cap: >= 50.00BDividend Yield Ttm: 2.50 - 6Analyst Consensus: Strong Buy, Moderate BuyBeta: LowRiskRevenue 5yr Cagr: >= 7
Ticker
Name
Market Cap$
top bottom
XOM logo
XOM
Exxon Mobil Corp
618.95B
CVX logo
CVX
Chevron Corp
368.92B
KO logo
KO
Coca-Cola Co
329.83B
UNH logo
UNH
UnitedHealth Group Inc
322.34B
MRK logo
MRK
Merck & Co Inc
276.38B
PM logo
PM
Philip Morris International Inc
255.91B
stock of the day
Intellectia · 13 candidates
Market Cap: >= 5.00BPrice Change Pct: >= $3.00Relative Vol: >= 1.50Moving Average Relationship: PriceAboveMA20Monthly Average Dollar Volume: >= 1,000,000
Ticker
Name
Market Cap$
top bottom
CAR logo
CAR
Avis Budget Group Inc
6.73B
SSL logo
SSL
Sasol Ltd
7.96B
UNH logo
UNH
UnitedHealth Group Inc
255.38B
PSKY logo
PSKY
Paramount Skydance Corp
10.95B
HUM logo
HUM
Humana Inc
21.93B
AAOI logo
AAOI
Applied Optoelectronics Inc
8.35B
money market funds
Intellectia · 68 candidates
Market Cap: >= 1000.00MRegion: USBeta: LowRisk, NegativeBetaList Exchange: XNYS, XNAS, XASEYear Price Change Pct: $2.00 - $8.00Monthly Average Dollar Volume: >= 100,000
Ticker
Name
Market Cap$
top bottom
KO logo
KO
Coca-Cola Co
321.48B
PM logo
PM
Philip Morris International Inc
252.94B
T logo
T
AT&T Inc
201.96B
CB logo
CB
Chubb Ltd
126.84B
SO logo
SO
Southern Co
106.81B
DUK logo
DUK
Duke Energy Corp
100.69B
best stocks to short
Intellectia · 70 candidates
Market Cap: >= 1000.00MPe Ttm: >= 40List Exchange: XNYS, XNAS, XASEMoving Average Relationship: PriceBelowMA200Annual Eps Yoy Growth: <= -10.0%Monthly Average Dollar Volume: >= 1,000,000
Ticker
Name
Market Cap$
top bottom
TSLA logo
TSLA
Tesla Inc
1.38T
SHOP logo
SHOP
Shopify Inc
152.29B
PANW logo
PANW
Palo Alto Networks Inc
132.97B
COF logo
COF
Capital One Financial Corp
112.86B
CEG logo
CEG
Constellation Energy Corp
102.16B
CVS logo
CVS
CVS Health Corp
90.94B
which has the highest return?
Intellectia · 14 candidates
Market Cap: >= 5.00BRegion: USPrice: $10.00 - $150.00One Day Rise Prob: >= 60One Day Predict Return: >= 3.0%Monthly Average Dollar Volume: >= 3,000,000
Ticker
Name
Market Cap$
top bottom
LNC logo
LNC
Lincoln National Corp
6.85B
CVS logo
CVS
CVS Health Corp
96.93B
RRR logo
RRR
Red Rock Resorts Inc
6.46B
PINS logo
PINS
Pinterest Inc
11.69B
MFC logo
MFC
Manulife Financial Corp
59.36B
QGEN logo
QGEN
Qiagen NV
10.06B

Whales Holding CVS

M
Mubadala Investment Company PJSC
Holding
CVS
+59.13%
3M Return
M
Maple Rock Capital Partners Inc.
Holding
CVS
+34.56%
3M Return
S
SRS Investment Management, LLC
Holding
CVS
+25.76%
3M Return
C
CCM Partners, LP
Holding
CVS
+21.31%
3M Return
B
Bridgewater Associates
Holding
CVS
+21.26%
3M Return
A
Argenta Asset Management SA
Holding
CVS
+20.17%
3M Return

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is CVS Health Corp (CVS) stock price today?

The current price of CVS is 90.98 USD — it has decreased -2.14

What is CVS Health Corp (CVS)'s business?

CVS Health Corporation is a health solutions company. The Company's segments include Health Care Benefits, Health Services, Pharmacy & Consumer Wellness and Corporate/Other. The Health Care Benefits segment offers a broad range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental and behavioral health plans, PDPs and Medicaid health care management services. The Health Services segment provides a full range of pharmacy benefit management (PBM) solutions through its CVS Caremark operations and delivers health care services in its medical clinics, virtually, and in the home. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its CVS Pharmacy retail locations and, through its infusion operations, provides ancillary pharmacy services including pharmacy patient care programs, and vaccination administration, and sells a wide assortment of health and wellness products and general merchandise.

What is the price predicton of CVS Stock?

Wall Street analysts forecast CVS stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CVS is96.71 USD with a low forecast of 91.00 USD and a high forecast of 105.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is CVS Health Corp (CVS)'s revenue for the last quarter?

CVS Health Corp revenue for the last quarter amounts to 100.43B USD, increased 6.17

What is CVS Health Corp (CVS)'s earnings per share (EPS) for the last quarter?

CVS Health Corp. EPS for the last quarter amounts to 2.30 USD, increased 63.12

How many employees does CVS Health Corp (CVS). have?

CVS Health Corp (CVS) has 300000 emplpoyees as of June 01 2026.

What is CVS Health Corp (CVS) market cap?

Today CVS has the market capitalization of 116.08B USD.